Cargando…
Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making
Model-informed drug development (MIDD) is a powerful approach to support drug development and regulatory review. There is a rich history of MIDD applications at the U.S. Food and Drug Administration (FDA). MIDD applications span across the life cycle of the development of new drugs, generics, and bi...
Autores principales: | Madabushi, Rajanikanth, Seo, Paul, Zhao, Liang, Tegenge, Million, Zhu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097888/ https://www.ncbi.nlm.nih.gov/pubmed/35552984 http://dx.doi.org/10.1007/s11095-022-03288-w |
Ejemplares similares
-
Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Jean, Daphney, et al.
Publicado: (2021) -
A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development
por: Madabushi, Rajanikanth, et al.
Publicado: (2019) -
Opportunities and challenges for applying model‐informed drug development approaches to gene therapies
por: Belov, Artur, et al.
Publicado: (2021) -
Model‐Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives
por: Marshall, Scott, et al.
Publicado: (2019) -
Advancing the science of patient input throughout the regulatory decision‐making process
por: Tegenge, Million A., et al.
Publicado: (2017)